News Sanofi

Equities

SAN

FR0000120578

Market Closed - Euronext Paris Other stock markets 11:37:48 2024-05-31 am EDT			5-day change	1st Jan Change
89.76 ^EUR	+1.34%		+0.27%	-.--%

10:07pm	Delaware judge lets more than 70,000 Zantac lawsuits go forward	RE
May. 31	CAC40: at the 8000 pts threshold, loses nearly 1.3% over the week	CF

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Delaware judge lets more than 70,000 Zantac lawsuits go forward	04:07pm	RE
CAC40: at the 8000 pts threshold, loses nearly 1.3% over the week	May. 31	CF
CAC40: remains at equilibrium despite sharp decline in Nasdaq and S&P	May. 31	CF
CAC40: May ends with no trend and a zero score	May. 31	CF
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review	May. 31	RE
Sanofi, Regeneron's Dupixent Receives Recommendation for Approval From European Medicines Agency Committee	May. 31	MT
Sanofi: launch of employee share ownership plan 2024	May. 31	CF
Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan	May. 31	GL
CAC40: stable trend before US inflation	May. 31	CF
Regeneron Pharmaceuticals, Sanofi Say Dupixent FDA Application Decision Delayed by 3 Months	May. 31	MT
Sanofi: positive opinion from the CHMP in COPD	May. 31	CF
CAC40: slightly positive bias before the opening	May. 31	CF
US FDA Delays Decision on Sanofi, Regeneron's Lung Disease Treatment Dupixent	May. 31	MT
Sanofi, Regeneron's Lung Disease Treatment Recommended for EU Approval	May. 31	MT
Sanofi's Dupixent Drug Review Date Extended by Three Months in the U.S.	May. 31	DJ
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD	May. 31	GL
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation	May. 31	GL
Regeneron Pharmaceuticals, Inc and Sanofi Announces Update on FDA Priority Review of Dupixent® for the Treatment of COPD Patients with Type 2 Inflammation	May. 31	CI
CAC40: regains some altitude, Airbus in support	May. 30	CF
Sanofi Closes Purchase of US Biotech Company Inhibrx	May. 30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SANOFI : Sanofi’s healthy Q1 performance hailed by markets

April 25, 2024 at 07:58 am EDT

Sanofi Sees Trend for Years of Steady Growth: CFO

February 03, 2023 at 03:56 pm EST